Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancer.
Reuben
James M
JM
Lee
Bang-Ning
BN
Li
Changping
C
Gao
Hui
H
Broglio
Kristine R
KR
Valero
Vicente
V
Jackson
Summer A
SA
Ueno
Naoto T
NT
Krishnamurthy
Savitri
S
Hortobagyi
Gabriel N
GN
Cristofanilli
Massimo
M
D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D009360:Neoplastic Cells, Circulating; D057285:Precision Medicine; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis
D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human